Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
PUT
Altisource Portfolio Solutions
ASPS
$64.3M
| $10M | ﹤0.01% |
38,688
+21,488
| +125% | +$5.06M |
|
|
CAVM
1527
PUT
DELISTED
Cavium, Inc.
CAVM
| $10M | ﹤0.01% |
172,300
+10,300
| +6% | +$516K |
|
1528
Casey's General Stores
CASY
$30.4B
| $10M | ﹤0.01% |
83,421
+81,421
| +4,071% | +$10.5M |
|
1529
PUT
Essex Property Trust
ESS
$18.6B
| $10M | ﹤0.01% |
45,000
+6,500
| +17% | +$1.48M |
|
1530
CALL
Aon
AON
$75.3B
| $10M | ﹤0.01% |
89,000
-29,200
| -25% | -$3.22M |
|
|
CAB
1531
PUT
DELISTED
Cabela's Inc
CAB
| $10M | ﹤0.01% |
182,200
+157,600
| +641% | +$8.07M |
|
1532
CALL
American Eagle Outfitters
AEO
$2.93B
| $9.98M | ﹤0.01% |
558,700
+167,900
| +43% | +$3.01M |
|
1533
Gold Fields
GFI
$42.5B
| $9.97M | ﹤0.01% |
2,056,874
-347,399
| -14% | -$1.97M |
|
|
JPHF
1534
DELISTED
JPMorgan Diversified Alternatives ETF
JPHF
| $9.96M | ﹤0.01% |
+393,818
| New | +$9.95M |
|
1535
PUT
Barclays
BCS
$91.3B
| $9.96M | ﹤0.01% |
1,214,747
-306,848
| -20% | -$2.42M |
|
1536
PUT
Wayfair
W
$14.4B
| $9.95M | ﹤0.01% |
252,800
-14,300
| -5% | -$578K |
|
|
CBPO
1537
PUT
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $9.95M | ﹤0.01% |
79,900
-4,100
| -5% | -$484K |
|
1538
KLA
KLAC
$239B
| $9.93M | ﹤0.01% |
1,423,830
+149,830
| +12% | +$1.08M |
|
1539
CALL
Northern Trust
NTRS
$34.2B
| $9.92M | ﹤0.01% |
145,900
-53,000
| -27% | -$3.6M |
|
|
PX
1540
PUT
DELISTED
Praxair Inc
PX
| $9.92M | ﹤0.01% |
82,100
+60,200
| +275% | +$7.13M |
|
1541
CALL
Raymond James Financial
RJF
$33.8B
| $9.9M | ﹤0.01% |
255,150
+27,750
| +12% | +$1.02M |
|
1542
CALL
Vanguard Dividend Appreciation ETF
VIG
$114B
| $9.86M | ﹤0.01% |
117,500
-59,100
| -33% | -$5.01M |
|
1543
PUT
Puma Biotechnology
PBYI
$469M
| $9.84M | ﹤0.01% |
146,800
+94,300
| +180% | +$4.77M |
|
|
AMAG
1544
DELISTED
AMAG Pharmaceuticals
AMAG
| $9.82M | ﹤0.01% |
400,540
+150,452
| +60% | +$3.76M |
|
1545
CALL
L3Harris
LHX
$48.8B
| $9.81M | ﹤0.01% |
107,100
+32,000
| +43% | +$2.84M |
|
1546
PUT
Aptiv
APTV
$9.6B
| $9.78M | ﹤0.01% |
137,100
-22,100
| -14% | -$1.49M |
|
1547
CALL
Zimmer Biomet
ZBH
$19.3B
| $9.78M | ﹤0.01% |
77,456
-12,463
| -14% | -$1.54M |
|
|
HAPN
1548
PUT
Happen Inc
HAPN
$2.11B
| $9.73M | ﹤0.01% |
314,840
+3,420
| +1% | +$88.8K |
|
1549
CALL
Paycom
PAYC
$10.4B
| $9.72M | ﹤0.01% |
193,900
+51,900
| +37% | +$2.53M |
|
|
MMP
1550
PUT
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $9.71M | ﹤0.01% |
137,200
+30,200
| +28% | +$2.15M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.99B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,278 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.